Socket Mobile is in the technology sector and is part of the computer hardware industry. The company CEO is Kevin J. Mills. Socket Mobile Inc is a producer of data capture products. The company’s products are integrated into mobile applications used in mobile point of sale mPOS, enterprise mobility, asset tracking and control systems.

Previous Intraday Performance:

The SCKT shares had a previous change of -3.82% which opened at 2.04 and closed at 1.96. It moved to an intraday high of 2.09 and a low of 1.96.

PR Newswire:  Socket Mobile Announces 2019 First Quarter Results Release Date and Conference Call

Historical Performance:

Over the last five trading days, SCKT shares returned -5.63% and in the past 30 trading days it returned -2.96%. Over three months, it changed -3.45%. In one year it has changed -37.78% and within that year its 52-week high was 3.14 and its 52-week low was 1.35. SCKT stock is 45.19% above its 52 Week Low.

Our calculations result in a 200 day moving average of 2.10 and a 50 day moving average of 1.99. Right now, SCKT stock is trading -6.47% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

PR Newswire:  Socket Mobile Announces 2019 First Quarter Results Release Date and Conference Call


The company has a market cap of $11.8m with 6.0m shares outstanding and a float of 4.7m shares. Trading volume was 828 shares and has experienced an average volume of 10,241 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for Socket Mobile was -0.08 which ended on 31st of December 2018.

Base on our calculations, the intrinsic value per share is 0.99, which means it might overvalued by -97.93%

The next earnings report will be: 05-02-2019

The long-term trend of the EPS is an important number as it indicates the present value of Socket Mobile; it is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -20.20% over the last twelve months.

Indicators Also to Watch:

Based on the latest filings, there is 22.00% of insider ownership and 8.60% of institutional ownership.

I calculated the beta to be 0.42

PR Newswire:  Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -3.85%, return on assets is -3.07%, profit margin is -2.77%, price-to-sales is 0.98 and price-to-book is 0.99.

Company Score Card:

Results are out of six:
 3  : Growth Expectations Result
 5  : Financial Safety Result
 0  : Past Performance Result
 1  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here